Evidence map›Paper›PMID 39063183›Full record

ArticleInternational journal of molecular sciences2024

Clinical and Molecular Characterization of

Giovanna Forte, Antonia Lucia Buonadonna, Candida Fasano, Paola Sanese, Filomena Cariola, Andrea Manghisi, Anna Filomena Guglielmi, Martina Lepore Signorile, Katia De Marco, Valentina Grossi and 2 more

Abstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Giovanna ForteMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Antonia Lucia BuonadonnaMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Candida FasanoMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0001-5878-3480
Paola SaneseMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Filomena CariolaMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Andrea ManghisiMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Anna Filomena GuglielmiMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Martina Lepore SignorileMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Katia De MarcoMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Valentina GrossiMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0003-3843-1618
Vittoria DisciglioMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Cristiano SimoneMedical Genetics, National Institute of Gastroenterology-IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.

Funding

Italian Association for Cancer Research (AIRC) ID26678-2021 AIRC Fellowship for Italy to M.L.S.Italian Association for Cancer Research (AIRC) IG-23794 to C.S.Italian Ministry of Health Ricerca Corrente 2023-2025" to V.G.Italian Ministry of Health "Ricerca Corrente 2024-2026" to C.F. and V.D.Italian Ministry of Health Ricerca Corrente 2024-2026 to C.S.Italian Ministry of Health Starting Grant SG-2019-12371540 to P.S.
6 · The paper itself

Abstract

Juvenile polyposis syndrome (JPS) is an inherited autosomal dominant condition that predisposes to the development of juvenile polyps throughout the gastrointestinal (GI) tract, and it poses an increased risk of GI malignancy. Germline causative variants were identified in the

Indexed as

Intestinal PolyposisNeoplastic Syndromes, HereditaryRNA SplicingSmad4 ProteinAdultFemaleGerm-Line MutationHumansIntronsMaleMiddle AgedPedigreeSmad4 ProteinSMAD4 protein, humanjuvenile polyposis syndromeSMAD4splicing variantsvariant of uncertain significance

Identifiers

PMID39063183
PMCPMC11276957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.